358 related articles for article (PubMed ID: 23103984)
81. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
82. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
83. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
84. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
85. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
86. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
[TBL] [Abstract][Full Text] [Related]
87. A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment.
Zhang Y; Tang L; Sun L; Bao J; Song C; Huang L; Liu K; Tian Y; Tian G; Li Z; Sun H; Mei L
Acta Biomater; 2010 Jun; 6(6):2045-52. PubMed ID: 19969111
[TBL] [Abstract][Full Text] [Related]
88. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
[TBL] [Abstract][Full Text] [Related]
89. Preparation and evaluation of lipid emulsified docetaxel-loaded nanoparticles.
Zhang F; Chang M; Yu Y; Zhang Y; Liu G; Wei T; Zuo T; Guan Y; Lin G; Zhao Z
J Pharm Pharmacol; 2015 Nov; 67(11):1546-55. PubMed ID: 26256262
[TBL] [Abstract][Full Text] [Related]
90. Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.
Cirstoiu-Hapca A; Buchegger F; Lange N; Bossy L; Gurny R; Delie F
J Control Release; 2010 Jun; 144(3):324-31. PubMed ID: 20219607
[TBL] [Abstract][Full Text] [Related]
91. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging.
Yuk SH; Oh KS; Cho SH; Lee BS; Kim SY; Kwak BK; Kim K; Kwon IC
Biomacromolecules; 2011 Jun; 12(6):2335-43. PubMed ID: 21506550
[TBL] [Abstract][Full Text] [Related]
92. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer.
Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y
Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687
[TBL] [Abstract][Full Text] [Related]
93. Mucoadhesive polyacrylamide nanogel as a potential hydrophobic drug carrier for intravesical bladder cancer therapy.
Lu S; Neoh KG; Kang ET; Mahendran R; Chiong E
Eur J Pharm Sci; 2015 May; 72():57-68. PubMed ID: 25772330
[TBL] [Abstract][Full Text] [Related]
94. Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation.
Tian JL; Ke X; Chen Z; Wang CJ; Zhang Y; Zhong TC
Pharmazie; 2011 May; 66(5):362-7. PubMed ID: 21699070
[TBL] [Abstract][Full Text] [Related]
95. Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy.
Yang D; Van S; Shu Y; Liu X; Ge Y; Jiang X; Jin Y; Yu L
Int J Nanomedicine; 2012; 7():581-9. PubMed ID: 22334784
[TBL] [Abstract][Full Text] [Related]
96. Self-assembly nanoparticles for the delivery of bisphosphonates into tumors.
Salzano G; Marra M; Porru M; Zappavigna S; Abbruzzese A; La Rotonda MI; Leonetti C; Caraglia M; De Rosa G
Int J Pharm; 2011 Jan; 403(1-2):292-7. PubMed ID: 21055454
[TBL] [Abstract][Full Text] [Related]
97. In vitro and in vivo anti-cancer effects of targeting and photothermal sensitive solid lipid nanoparticles.
Zhu X; Huang S; Huang H; Zhang Y; Xie Y; Hou L; Zhang H; Shi J; Zhang Z
J Drug Target; 2014 Nov; 22(9):822-8. PubMed ID: 24964053
[TBL] [Abstract][Full Text] [Related]
98. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
[TBL] [Abstract][Full Text] [Related]
99. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
[TBL] [Abstract][Full Text] [Related]
100. Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel.
de Oliveira R; Zhao P; Li N; de Santa Maria LC; Vergnaud J; Ruiz J; Astruc D; Barratt G
Int J Pharm; 2013 Oct; 454(2):703-11. PubMed ID: 23701998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]